Clinical Trials Logo

Neuropathic Pain clinical trials

View clinical trials related to Neuropathic Pain.

Filter by:

NCT ID: NCT05975281 Not yet recruiting - Neuropathic Pain Clinical Trials

Neuropathic Pain Symptoms in Arthritis

Start date: July 27, 2023
Phase:
Study type: Observational

It was aimed to compare neuropathic pain symptoms in hand osteoarthritis and rheumatoid arthritis.

NCT ID: NCT05968664 Not yet recruiting - Chronic Pain Clinical Trials

Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation

Start date: January 2024
Phase: N/A
Study type: Interventional

The goal of this study is to compare pain outcomes achieved by spinal cord stimulation (SCS) using time varying stimulation patterns with pain outcomes achieved by current standard of care SCS.

NCT ID: NCT05949554 Not yet recruiting - Neuropathic Pain Clinical Trials

Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.

KetEEG
Start date: September 2023
Phase:
Study type: Observational

Chronic pain symptoms can lead to sleep and mood disorders, restrict domestic and work activities and have a significant impact on quality of life. The prevalence of chronic pain in the general population varies between 10 and 52% depending on the study, 7% of which is neuropathic pain. Anxiety-depression comorbidities are found in a large number of patients, with harmful consequences on pain since they exacerbate symptoms and their repercussions. Conversely, pain increases psychological distress. Ketamine has been used in the context of depressive episodes for its rapid action. It is also increasingly used in chronic pain due to its ability to regulate the "wind-up" effect, a phenomenon involved in the central hypersensitization that is inevitably present in neuropathic pain of prolonged duration. Several studies have found electroencephalographic (EEG) signatures associated with a good antidepressant response to Ketamine. The frequency, absolute and relative power and cordance of the EEG signal in certain frequency ranges (theta, alpha, beta and gamma) could be useful to guide and adapt therapies for depression and pain.

NCT ID: NCT05900791 Not yet recruiting - Opioid Use Clinical Trials

Persistent Pain After Knee Replacement

Start date: November 1, 2023
Phase:
Study type: Observational

This study is a nationwide cross-sectional survey on pain and satisfaction after knee arthroplasty (KA). Please find the full protocol uploaded at ClinicalTrials.gov The goal of this observational study is to study pain and satisfaction in patients operated with knee arthroplasty. The main question it aims to answer are: - What is the incidence of persistent postsurgical pain in unselected knee arthroplasty patients - What is the level of satisfaction in unselected knee arthroplasty patients? Participants will be asked to answer a 22-item questionnaire.

NCT ID: NCT05735574 Not yet recruiting - Chronic Pain Clinical Trials

Determining Cost of Explant of Neurmodulation Device Due to Infection

Start date: March 1, 2023
Phase:
Study type: Observational

Spinal cord stimulation (SCS) is a medical device inserted beside the spine to treat nerve pain. When the device becomes infected (which happens 4 % of the time) it needs to be taken out and put back in again at a later date. So far we are unsure of how much this process costs. I am going to analyse data collected on a database of all devices taken out due to infection and calculate an average cost of taking them out, the intermediate care and putting them back in again in our hospital only. This will enable us to understand how much this process costs and if there are any methods of reducing the chance of infection in the future; we will be able to work out how much the NHS should pay for these products based on this data. This will be done in Guys and St Thomas's from a database in the chronic pain research department in patients who had their device taken out due to infection. It will take 6 months and will all be retrospective. Additional details may be collected from patients electronic records where needed. These will be collected by a member of the direct care team and pseudonymised prior to adding to the research data set.

NCT ID: NCT05630235 Not yet recruiting - Neuropathic Pain Clinical Trials

Effects of Cannabidiol (CBD) on Resting-state Electroencephalography (EEG) and Neuropathic Pain Severity in People With Spinal Cord Injury (SCI)

Start date: July 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The main purposes of this study are to (1) measure the effect of CBD on pain symptoms, pain intensity, pain unpleasantness, and skin sensitivity to hot and cold temperature; and (2) measure the effect of CBD on brain electrical activity with electroencephalography (EEG).

NCT ID: NCT05505188 Not yet recruiting - Sleep Clinical Trials

Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer

DIP-CAOS
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Head and neck cancers are a source of complications and after-effects related to the disease and treatment. These cancers and their treatment alter the quality of life of patients and generate pain with physical and psychological components. Chronic pain affects 36% of patients at 6 months and 30% after this period. These pains are responsible for the consumption of level II and III analgesics in 53% of these patients. At the same time, after the end of treatment, nearly a quarter of patients continued to smoke and half still consumed alcohol at least twice a week. The hypothesis of this research is to investigate the correlation between pain and the continuation of addictions, the occurrence of depressive states, asthenia and the alteration of the patients' global quality of life. The investigators propose a two-center prospective cohort study to evaluate this hypothesis at 6 months after radiotherapy treatment. This study is planned to include 120 patients with a first head and neck cancer whit radiotherapy as part of their treatment sequence. The expected duration of inclusion is 18 months. The identification of factors affecting survival, quality of life and patient compliance is essential to determine appropriate management, particularly by creating appropriate therapeutic education programs.

NCT ID: NCT05351008 Not yet recruiting - Chronic Pain Clinical Trials

The Improvement of Physical Therapy Through Cognitive Techniques in Patients With Chronic Pain

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This research will provide a better understanding of the interaction of chronic neuropathic pain and its interaction with the mental state. In addition, he will compare the results of simple classical physiotherapy intervention with cognitive physiotherapy intervention in chronic neuropathic pain. Finally, it will highlight the usefulness of integrating elements of cognitive-behavioral therapy in physiotherapy intervention to achieve a comprehensive anthropocentric therapy.

NCT ID: NCT05101837 Not yet recruiting - Migraine Clinical Trials

Feasibility and Effectiveness of a Specific App to Delivery Mindfulness Sessions

BE_BI_MIND_APP
Start date: October 2021
Phase: N/A
Study type: Interventional

A standardized behavioural approach based on mindfulness delivered mainly by a specific APP on android will be developed and applied for patients with chronic pain conditions, as migraine and neuropathic pain. The aim of this pilot study: The investigators propose a pilot study to enforce the application of a Home-program for patients with different pain conditions, to learn mindfulness practice, added to a regular mindfulness guided face-to-face program, by using the technology with android to receive mindfulness sessions for daily practice and to assess the feasibility and the effectiveness of behavioural approach base on mindfulness delivered with this modality.

NCT ID: NCT04897425 Not yet recruiting - Neuropathic Pain Clinical Trials

Mindful SensoriMotor Therapy With Brain Modulation in Highly Impaired Extremities

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Brief summary: This single-arm, pilot clinical investigation aims to evaluate Mindful SensoriMotor Therapy (MSMT) enhanced with brain modulation as a treatment of pain due to sensorimotor impairment, such as Phantom Limb Pain (PLP). MSMT consists of consciously retraining the motor and sensory networks used by the missing limb via myoelectric pattern recognition and haptic feedback. In this trial, we further enhance the effect of MSMT by brain modulation, transcranial Direct Current Stimulation (tDCS).